Japanese Healthy Adult Male Participants Clinical Trial
Official title:
A Randomized, Open Label, 2-Period, 2-Treatment, Cross-over Phase 1 Study to Evaluate the Bio-equivalence of Single Oral Dose of TAK-536 Pediatric Formulation and TAK-536 Commercial Formulation in Healthy Adult Male Subjects
The purpose of this study is to evaluate the bio-equivalence of a single oral administration of TAK-536 pediatric formulation (granules) in comparison with a TAK-536 commercial formulation (tablet) in Japanese healthy adult male participants in an open label, 2-period, 2-treatment, cross-over design.
The purpose of this study is to evaluate the bio-equivalence of a single oral administration of TAK-536 pediatric formulation (granules) in comparison with a TAK-536 commercial formulation (tablet) in healthy adult male participants in an open label, 2-period, 2-treatment, cross-over design. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02902978 -
A Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects
|
Phase 1 | |
| Completed |
NCT03237156 -
Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Participants
|
Phase 1 |